Company registration number 10966240 (England and Wales)
BH Therapeutic Systems Limited
Unaudited Financial Statements
For the year ended 30 September 2025
BH Therapeutic Systems Limited
Contents
Page
Statement of financial position
1
Notes to the financial statements
2 - 5
BH Therapeutic Systems Limited
Statement of financial position
As at 30 September 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
6,966
8,383
Current assets
Cash at bank and in hand
12
3,248
Creditors: amounts falling due within one year
4
(4,730)
(9,333)
Net current liabilities
(4,718)
(6,085)
Total assets less current liabilities
2,248
2,298
Provisions for liabilities
(1,300)
(1,600)
Net assets
948
698
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
848
598
Total equity
948
698

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 12 January 2026
Mrs B O Haughton
Director
Company registration number 10966240 (England and Wales)
BH Therapeutic Systems Limited
Notes to the financial statements
For the year ended 30 September 2025
- 2 -
1
Accounting policies
Company information

BH Therapeutic Systems Limited is a private company limited by shares incorporated in England and Wales. The registered office is 10 Oldhill Close, Talke Pits, Stoke on Trent, Staffordshire, ST7 1RD.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
15% Per annum on cost
Computer equipment
20% per annum on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

BH Therapeutic Systems Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
1
Accounting policies
(Continued)
- 3 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

1.5
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

BH Therapeutic Systems Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
1
3
Tangible fixed assets
BH Therapeutic Systems Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
3
Tangible fixed assets
(Continued)
- 5 -
Fixtures and fittings
Computer equipment
Total
£
£
£
Cost
At 1 October 2024 and 30 September 2025
11,600
2,498
14,098
Depreciation and impairment
At 1 October 2024
4,249
1,466
5,715
Depreciation charged in the year
1,103
314
1,417
At 30 September 2025
5,352
1,780
7,132
Carrying amount
At 30 September 2025
6,248
718
6,966
At 30 September 2024
7,351
1,032
8,383
4
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
360
7,320
Other creditors
4,370
2,013
4,730
9,333
2025-09-30 2024-10-01 false false false 12 January 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mrs B O Haughton 10966240 2024-10-01 2025-09-30 10966240 2025-09-30 10966240 2024-09-30 10966240 core:FurnitureFittings 2025-09-30 10966240 core:ComputerEquipment 2025-09-30 10966240 core:FurnitureFittings 2024-09-30 10966240 core:ComputerEquipment 2024-09-30 10966240 core:CurrentFinancialInstruments 2025-09-30 10966240 core:CurrentFinancialInstruments 2024-09-30 10966240 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 10966240 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 10966240 core:ShareCapital 2025-09-30 10966240 core:ShareCapital 2024-09-30 10966240 core:RetainedEarningsAccumulatedLosses 2025-09-30 10966240 core:RetainedEarningsAccumulatedLosses 2024-09-30 10966240 bus:Director1 2024-10-01 2025-09-30 10966240 core:FurnitureFittings 2024-10-01 2025-09-30 10966240 core:ComputerEquipment 2024-10-01 2025-09-30 10966240 2023-10-01 2024-09-30 10966240 core:FurnitureFittings 2024-09-30 10966240 core:ComputerEquipment 2024-09-30 10966240 2024-09-30 10966240 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 10966240 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 10966240 bus:FRS102 2024-10-01 2025-09-30 10966240 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 10966240 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP